Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers medical instrument disinfection products, including airway management, cardiology, ear, nose and throat, endoscopy, gastrointestinal physiology, laboratory, ophthalmology, phlebotomy, reproductive health/IVF, surface, ultrasound, urology, women's health, and other products under the Tristel brand. Tristel plc was founded in 1993 and is headquartered in Snailwell, the United Kingdom.
Stock data | 2023 | Change |
---|---|---|
Price | $5.47 | N/A |
Market Cap | $258.38M | N/A |
Shares Outstanding | 47.25M | 0.13% |
Employees | 208.00 | N/A |
Shareholder Equity | 30.68M | 3.33% |
Valuation | 2023 | Change |
---|---|---|
P/E Ratio | 58.55 | N/A |
P/S Ratio | 5.44 | N/A |
P/B Ratio | 8.42 | N/A |
Growth | 2023 | Change |
---|---|---|
Return on Equity | 0.1919 | N/A |
Earnings | 2023 | Change |
---|---|---|
Revenue | $47.53M | N/A |
Earnings | $5.89M | N/A |
EPS | 0.0934 | N/A |
Earnings Yield | 0.0171 | N/A |
Gross Margin | 0.8102 | N/A |
Operating Margin | 0.1467 | N/A |
Net income margin | 0.1239 | N/A |
Financial Strength | 2023 | Change |
---|---|---|
Total Assets | $54.60M | N/A |
Total Debt | $6.84M | N/A |
Cash on Hand | $12.60M | N/A |
Debt to Equity | 0.4596 | 3.52% |
Cash to Debt | $1.84 | 20.23% |
Current Ratio | $3.88 | -14.96% |